HK1081101A1 - Deferasirox dispersible tablets - Google Patents

Deferasirox dispersible tablets

Info

Publication number
HK1081101A1
HK1081101A1 HK06101089.4A HK06101089A HK1081101A1 HK 1081101 A1 HK1081101 A1 HK 1081101A1 HK 06101089 A HK06101089 A HK 06101089A HK 1081101 A1 HK1081101 A1 HK 1081101A1
Authority
HK
Hong Kong
Prior art keywords
dispersible tablets
deferasirox
deferasirox dispersible
tablets
dispersible
Prior art date
Application number
HK06101089.4A
Other languages
English (en)
Inventor
Karine Deffez
Jean-Pierre Cassiere
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9945957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1081101(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1081101A1 publication Critical patent/HK1081101A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
HK06101089.4A 2002-10-15 2006-01-24 Deferasirox dispersible tablets HK1081101A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0223978.8A GB0223978D0 (en) 2002-10-15 2002-10-15 Organic compound
PCT/EP2003/011351 WO2004035026A1 (en) 2002-10-15 2003-10-14 Deferacirox dispersible tablets

Publications (1)

Publication Number Publication Date
HK1081101A1 true HK1081101A1 (en) 2006-05-12

Family

ID=9945957

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101089.4A HK1081101A1 (en) 2002-10-15 2006-01-24 Deferasirox dispersible tablets

Country Status (34)

Country Link
US (5) US20060110446A1 (xx)
EP (1) EP1556013B8 (xx)
JP (4) JP2006504748A (xx)
KR (1) KR100765580B1 (xx)
CN (2) CN101912391A (xx)
AR (1) AR041609A1 (xx)
AT (1) ATE431138T1 (xx)
AU (1) AU2003278078B2 (xx)
BR (1) BR0315264A (xx)
CA (1) CA2501659C (xx)
CY (1) CY1109902T1 (xx)
DE (1) DE60327646D1 (xx)
DK (1) DK1556013T3 (xx)
EC (1) ECSP055733A (xx)
EG (1) EG25453A (xx)
ES (1) ES2326167T3 (xx)
GB (1) GB0223978D0 (xx)
HK (1) HK1081101A1 (xx)
IL (1) IL167709A (xx)
JO (1) JO2700B1 (xx)
MX (1) MXPA05003999A (xx)
MY (1) MY140999A (xx)
NO (1) NO336958B1 (xx)
NZ (1) NZ539354A (xx)
PA (1) PA8586501A1 (xx)
PE (1) PE20040496A1 (xx)
PL (1) PL213325B1 (xx)
PT (1) PT1556013E (xx)
RU (1) RU2338532C2 (xx)
SI (1) SI1556013T1 (xx)
TN (1) TNSN05109A1 (xx)
TW (1) TWI339657B (xx)
WO (1) WO2004035026A1 (xx)
ZA (1) ZA200502488B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0408078D0 (en) * 2004-04-08 2004-05-12 Novartis Ag Organic compounds
JP2009512652A (ja) * 2005-10-19 2009-03-26 ノバルティス アクチエンゲゼルシャフト 安息香酸誘導体含有分散錠
US20090317489A1 (en) 2006-05-09 2009-12-24 Hanspeter Nick Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof
TWI448285B (zh) 2006-07-13 2014-08-11 Los Angeles Biomed Res Inst 用以治療白黴菌症（ｍｕｃｏｒｍｙｃｏｓｉｓ）及其他真菌類疾病之組合物及方法
EP1994930A1 (en) 2007-05-22 2008-11-26 Novartis AG Triazol compounds for treating biofilm formation
WO2009016359A1 (en) * 2007-07-27 2009-02-05 Pliva Hrvatska D.O.O. New forms of deferasirox
EP2062572A1 (en) 2007-11-19 2009-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions
WO2009106824A2 (en) * 2008-02-25 2009-09-03 Cipla Limited Pharmaceutical formulations
JPWO2010032489A1 (ja) 2008-09-22 2012-02-09 国立大学法人旭川医科大学 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法
WO2010092419A1 (en) 2009-02-12 2010-08-19 Assistance Publique - Hopitaux De Paris Combined treatment of multiple sclerosis
WO2010107500A1 (en) 2009-03-19 2010-09-23 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
ES2543427T3 (es) 2010-07-08 2015-08-19 Ratiopharm Gmbh Forma farmacéutica oral de deferasirox
PE20170468A1 (es) 2010-10-01 2017-04-26 Cipla Ltd Composicion farmaceutica que comprende deferasirox
EP2664333B1 (en) 2011-01-14 2016-10-12 Disease Adsorption System Technologies Co., Ltd. Polymeric iron chelating agent
AU2013343250A1 (en) 2012-11-12 2015-04-09 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferipone
NZ711179A (en) 2013-03-08 2018-07-27 Novartis Ag Oral formulations of deferasirox
AU2014264421A1 (en) 2013-05-10 2015-12-03 Cipla Limited Low dose pharmaceutical composition
CN103735519A (zh) * 2014-01-10 2014-04-23 无锡万全医药技术有限公司 一种地拉罗司颗粒剂及其制备方法
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
KR20160088965A (ko) 2015-01-16 2016-07-27 대원제약주식회사 데페라시록스를 함유하는 현탁제
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
EP3095443A1 (en) 2015-05-21 2016-11-23 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Pharmaceutical composition comprising deferasirox
KR101695970B1 (ko) 2015-07-31 2017-01-13 건일제약 주식회사 데페라시록스 함유 산제 및 그 제조방법
US20190091204A1 (en) 2016-03-17 2019-03-28 Lupin Limited Compositions of deferasirox
EP3248594A1 (en) * 2016-05-25 2017-11-29 ratiopharm GmbH Tablet for multiple oral applications
EP3518904A1 (en) 2016-09-30 2019-08-07 Synthon B.V. Pharmaceutical composition comprising deferasirox
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
TR201707764A2 (tr) * 2017-05-29 2018-12-21 Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasiroksun bölünebilir tablet formları.
EP3675832A1 (en) 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
WO2019108157A1 (en) * 2017-11-28 2019-06-06 Biofarma Ilac Sanayi Ve Ticaret A.S. A scored tablet formulation in a dispersible form comprising deferasirox
WO2019108156A1 (en) * 2017-11-28 2019-06-06 Biofarma Ilac Sanayi Ve Ticaret A.S. A scored tablet formulation comprising deferasirox in a film tablet form
TR201722910A2 (tr) * 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
KR20190110771A (ko) 2018-03-21 2019-10-01 주식회사 한국팜비오 데페라시록스를 함유하는 소형 분산성 정제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU120988A (en) * 1988-06-23 1990-06-30 Lek Tovarna Farmacevtskih Process for preparing new dispersion pills of cimetidine
YU183988A (en) * 1988-09-30 1990-08-31 Lek Tovarna Farmacevtskih Process for preparing dispersion pills of dihydroergotoxine
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DE4412117A1 (de) * 1994-04-08 1995-10-12 Fette Wilhelm Gmbh Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen
TW533205B (en) * 1996-06-25 2003-05-21 Novartis Ag Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition
JP4117811B2 (ja) * 1997-04-22 2008-07-16 日本化薬株式会社 フルタミド製剤及びその製法
KR20010042536A (ko) * 1998-04-08 2001-05-25 히라타 다다시 정제의 제조방법 및 정제
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤
JP2000086503A (ja) * 1998-09-07 2000-03-28 Pola Chem Ind Inc 錠剤医薬組成物
KR100720877B1 (ko) * 1998-12-28 2007-05-22 다케다 야쿠힌 고교 가부시키가이샤 비타민 제제
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
JP2002033764A (ja) * 2000-07-14 2002-01-31 Fujitsu Ltd 通信サービス提供システム、並びに通信サービス提供システムにおいて使用される移動端末装置、アドレスサーバ装置、およびルータ装置
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠

Also Published As

Publication number Publication date
NO20052335D0 (no) 2005-05-12
TWI339657B (en) 2011-04-01
CA2501659A1 (en) 2004-04-29
JO2700B1 (en) 2013-03-03
ATE431138T1 (de) 2009-05-15
BR0315264A (pt) 2005-08-23
PA8586501A1 (es) 2005-02-04
WO2004035026A1 (en) 2004-04-29
ECSP055733A (es) 2005-07-06
US20060110446A1 (en) 2006-05-25
JP2006504748A (ja) 2006-02-09
MXPA05003999A (es) 2005-06-22
KR100765580B1 (ko) 2007-10-09
AU2003278078A1 (en) 2004-05-04
EP1556013B1 (en) 2009-05-13
DK1556013T3 (da) 2009-08-17
PT1556013E (pt) 2009-08-10
PE20040496A1 (es) 2004-09-20
US20110046193A1 (en) 2011-02-24
PL375166A1 (en) 2005-11-28
AU2003278078B2 (en) 2007-08-02
CN1705471A (zh) 2005-12-07
JP2014088417A (ja) 2014-05-15
US20120196909A1 (en) 2012-08-02
CY1109902T1 (el) 2014-09-10
ZA200502488B (en) 2005-11-30
NO20052335L (no) 2005-07-15
KR20050071578A (ko) 2005-07-07
PL213325B1 (pl) 2013-02-28
TW200410949A (en) 2004-07-01
SI1556013T1 (sl) 2009-10-31
IL167709A (en) 2015-05-31
CN101912391A (zh) 2010-12-15
US20110319457A1 (en) 2011-12-29
EP1556013A1 (en) 2005-07-27
JP5908505B2 (ja) 2016-04-26
RU2338532C2 (ru) 2008-11-20
GB0223978D0 (en) 2002-11-20
CA2501659C (en) 2011-08-23
NO336958B1 (no) 2015-12-07
US20160175255A1 (en) 2016-06-23
JP2016094435A (ja) 2016-05-26
ES2326167T3 (es) 2009-10-02
JP2010031022A (ja) 2010-02-12
DE60327646D1 (de) 2009-06-25
EP1556013B8 (en) 2010-03-03
EG25453A (en) 2012-01-19
AR041609A1 (es) 2005-05-26
TNSN05109A1 (en) 2007-05-14
RU2005114904A (ru) 2006-01-27
NZ539354A (en) 2007-04-27
MY140999A (en) 2010-02-12

Similar Documents

Publication Publication Date Title
HK1081101A1 (en) Deferasirox dispersible tablets
GB0303210D0 (en) Early entry
GB0204771D0 (en) Fast disintegrating tablets
GB0403532D0 (en) Early entry
AU2003263737A8 (en) Pre-aligner
GB0212948D0 (en) Manipulator
EP1548110A4 (en) TRANSGLUTAMINASE-PRODUCING STRAIN
GB0209608D0 (en) Early entry
GB0210223D0 (en) Easily dispersible powder product
GB0317960D0 (en) Early entry
AU2003259908A8 (en) Antenna-coupled microbolometer
EP1574454A4 (en) CASING
AU2003300664A8 (en) Kiosk
GB0223273D0 (en) Sensors
GB0209610D0 (en) Early entry
EP1564156A4 (en) BOX
AU148729S (en) Tablet
AU148728S (en) Tablet
AU148730S (en) Tablet
AU147578S (en) Tablet
GB0208946D0 (en) Future
GB0207451D0 (en) Sensors
GB0214951D0 (en) Modular sightscreen
GB0210564D0 (en) Concept four
PL113361U1 (en) Case

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20231013